Taxotere Hair Loss Lawsuit News

How Women Think About Chemotherapy Hair Loss

Women are much different than men when it comes to their hair

Monday, December 11, 2017 - Doctors preoccupied with saving lives may not properly warn their cancer patients of the permanent hair loss side effects of chemotherapy.

The adverse side effects of anti-cancer chemotherapy drug Taxotere are so severe that some cancer patients would have rather died from the disease itself. Permanent, total baldness including the losing one's eyebrows, eyelashes, armpit and pubic hair is the after effects of receiving Taxotere cancer treatment in approximately 10% of Taxotere patients. Patients experiencing permanent rather than temporary hair loss feel betrayed by their oncologists that kept them in the dark as to the permanence of their expected hair loss and feel that they have the right to make an informed decision.

It is traumatic and tragic to receive a diagnosis that one has a life-threatening illness, cancer being at the top of the list of diseases most people fear the most. A cancer patient naturally wants all the facts pertaining to their new illness such as how long they have to live and what odds they have of even surviving. Some cancer patients are told that their cancer is so advanced that they may have less than a year to live. Doctors are quick to recommend a program of treatment for the disease such as surgically cutting the cancer out of the body and following up with chemotherapy. It is at this point that the patient wants to know what to expect from the side effects of each drug they are given will be. Of course, doctors have a responsibility to explain the straight facts to their patients even if it means that the news is so bad that the patient seeks a second opinion.

As thousands of women that have been given Taxotere have found out, permanent baldness should be the first thing a doctor points out to the patient. Doctors may gloss over the Alopecia risks, however, first by explaining, and only if asked, that approximately 10% of Taxotere patients experience permanent hair loss. Some doctors think that worrying about hair loss is a reflection of a person's vanity and not worth taking seriously. A doctor is worried about greater things like the life and death and their patient, and a patient should not be worrying about the way she looks. There is such a difference in thinking between how a male views hair loss and a woman's attachment to hair. Having head hair, manicured eyebrows, and lush eyelashes makes a woman feel feminine and desirable. On the contrary, being bald is associated with masculinity and not prioritizing one's appearance. No matter what they say a woman that is bald feels that the entire world looks at them as being sick or being a freak. Of course, a cancer patient first priority is to beat the disease and then to get on with a normal life. The latter is nearly impossible if one is totally and permanently bald.

Women are contacting Taxotere hair loss lawyers to file lawsuits against the maker of the drug, alleging that the company was aware of the potential for permanent hair loss and failed to warn patients of this risk and are therefore liable for damages.

More Recent Taxotere Hair Loss Lawsuit News:

Lawyers for Taxotere Hair Loss Lawsuits

Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.